Admedus Limited received notice from arcomed ag (arcomed) of its intention to terminate the distribution agreement with Admedus for the supply of arcomed branded products in Australia and New Zealand. The Company has previously announced a strategic vision to focus on its' structural heart initiatives and as such the Company's recent efforts have been to complete transactions that deliver better outcomes for the customers of the Company's Infusion business and their patients. The Company will work with affected customers over the coming months to ensure that there is no impact to patient care.